Thursday, February 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

Tick-Borne Disease Research Program

by Global Biodefense Staff
May 2, 2016
Tick-Borne Disease Research Program

Illustration depicts the Rocky Mountain wood tick, Dermacentor andersoni. This tick species is a known North American vector of Rickettsia rickettsii, which is the etiologic agent of Rocky Mountain spotted fever. Credit: Andre J. Brooks/CDC (1972)

Illustration depicts the Rocky Mountain wood tick, Dermacentor andersoni. This tick species is a known North American vector of Rickettsia rickettsii, which is the etiologic agent of Rocky Mountain spotted fever. Credit: Andre J. Brooks/CDC (1972)
Illustration depicts the Rocky Mountain wood tick, Dermacentor andersoni. This tick species is a known vector of Rickettsia rickettsii, which is the etiologic agent of Rocky Mountain spotted fever.
Credit: Andre J. Brooks/CDC (1972)

The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) has announced $5 million in funding available to support the recently established Tick-Borne Disease Research Program (TBDRP).

There are currently at least 16 known tick-borne illnesses, with emerging diseases being discovered all the time. In the United States, the yearly cases of Lyme disease and other tick-borne diseases, including spotted fever rickettsiosis, anaplasmosis, and ehrlichiosis, have been increasing steadily for years, currently totaling tens of thousands of people diagnosed annually, with more likely undiagnosed. Globally, the US Military prioritizes tick-borne Crimean-Congo hemorrhagic fever as an operational threat abroad.

The TBDRP is seeking research focused on understanding the pathogenesis of Lyme disease and other tick-borne illness and on delivering innovative solutions to prevent and better diagnose and treat their manifestations.

Highlighted areas of interest include:

  • Host-pathogen interactions
  • Human immune response
  • Mechanisms of persistence of Lyme disease
  • New research tools to support studies of pathogenesis
  • Direct detection of tick-borne pathogens in humans
  • Biomarkers for diagnosis
  • Personal protection measures
  • Targeted vaccines
  • Post-exposure prophylaxis
  • Innovative approaches to treatment
  • Biomarkers of effective prognosis, therapy and cure

The funding opportunity is in the ‘pre-announcement’ phase to allow investigators time to plan and develop applications. FY16 TBDRP Program Announcements and General Application Instructions are anticipated to be posted on the Grants.gov website in late June/early July 2016.

For email notification when the official program announcement is released, go to the Electronic Biomedical Research Application Portal and subscribe to program communications for the Tick-Borne Disease Research Program.

Tags: BiomarkersRequest for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC